JP2014201568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014201568A5 JP2014201568A5 JP2013080907A JP2013080907A JP2014201568A5 JP 2014201568 A5 JP2014201568 A5 JP 2014201568A5 JP 2013080907 A JP2013080907 A JP 2013080907A JP 2013080907 A JP2013080907 A JP 2013080907A JP 2014201568 A5 JP2014201568 A5 JP 2014201568A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- active ingredient
- prickly pear
- food composition
- ameliorating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000001439 Opuntia Species 0.000 claims 16
- 239000004480 active ingredient Substances 0.000 claims 16
- 235000013389 devils tongue Nutrition 0.000 claims 16
- 235000013305 food Nutrition 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 230000002730 additional Effects 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 230000003405 preventing Effects 0.000 claims 4
- 230000028327 secretion Effects 0.000 claims 4
- DTHNMHAUYICORS-KTKZVXAJSA-N 107444-51-9 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 102100003818 GCG Human genes 0.000 claims 2
- 101710042131 GCG Proteins 0.000 claims 2
- 101700071595 GRZ1 Proteins 0.000 claims 2
- 229960004666 Glucagon Drugs 0.000 claims 2
- 108060003199 Glucagon Proteins 0.000 claims 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N Glucagonum Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 2
- 206010022489 Insulin resistance Diseases 0.000 claims 2
- 101700078733 ZGLP1 Proteins 0.000 claims 2
- 230000004217 heart function Effects 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 230000000291 postprandial Effects 0.000 claims 2
- 230000003449 preventive Effects 0.000 claims 2
- 239000002830 appetite depressant Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
Claims (16)
善剤。 A prophylactic and / or ameliorating agent for insulin resistance comprising prickly pear or an extract thereof as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080907A JP2014201568A (en) | 2013-04-09 | 2013-04-09 | Glp-1 secretion promoter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080907A JP2014201568A (en) | 2013-04-09 | 2013-04-09 | Glp-1 secretion promoter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014201568A JP2014201568A (en) | 2014-10-27 |
| JP2014201568A5 true JP2014201568A5 (en) | 2016-07-07 |
Family
ID=52352331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013080907A Pending JP2014201568A (en) | 2013-04-09 | 2013-04-09 | Glp-1 secretion promoter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2014201568A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7500715B2 (en) * | 2019-09-30 | 2024-06-17 | シャンハイ インスティチュート オブ マテリア メディカ，チャイニーズ アカデミー オブ サイエンシーズ | Drugs for treating arterial-related diseases and their uses |
-
2013
- 2013-04-09 JP JP2013080907A patent/JP2014201568A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501131A1 (en) | Composition for treating hyperlipidemia comprising oxytomodulin derivative | |
| MY188344A (en) | Extract formulations of rhodamnia cinerea and uses thereof | |
| PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
| MX2022004041A (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same. | |
| CL2016002132A1 (en) | Use of an amount of laquinimod, which is used to prepare a medication to treat a human patient affected with multiple sclerosis or who has a clinically isolated syndrome; a package, an amount of laquinimod and a pharmaceutical composition thereof. | |
| MA40466A (en) | Use of a long acting glp-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease | |
| PH12015500688A1 (en) | Exendin-4 derivatives as dual glp1/glucagon agonists | |
| MX2016013244A (en) | Exendin-4 derivatives as peptidic dual glp-1 / glucagon receptor agonists. | |
| WO2017009236A3 (en) | New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists | |
| PH12018500261B1 (en) | Azole benzene derivative | |
| TN2018000038A1 (en) | Inhibitor of the mutated isocitrate dehydrogenase idh1 r132h | |
| WO2010087565A3 (en) | Novel use of piperine | |
| PH12017501205A1 (en) | Glucagon derivatives | |
| JP2014201568A5 (en) | ||
| WO2015042495A3 (en) | Metformin salts to treat type2 diabetes | |
| JP2014201567A5 (en) | ||
| MX346646B (en) | Pharmaceutical formulation of 4-dimethylamino pyridine decavanadate and derivatives thereof for preventing metabolic syndrome, obesity and diabetes type 2. | |
| UA114792C2 (en) | Glucagpn/glp-1 receptor co-agonists |